Amneal to Report First Quarter 2023 Results on May 5, 2023

BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its first quarter 2023 financial results on Friday May 5, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on May 5, 2023. The financial results … [Read more…]

PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, … [Read more…]

Caraway Therapeutics to Present at 22nd Annual Needham Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the 22nd Annual Needham Healthcare Conference, taking place April 17-20, 2023. Caraway’s Chief Executive Officer, Martin D. Williams, will present recent advances in the Company’s preclinical TRPML1 programs on April 19 from 11:00 – 11:40 AM ET. The Company will also be … [Read more…]

Gennao Bio Announces Appointment of Christopher Duke as Chief Executive Officer

HOPEWELL, N.J.–(BUSINESS WIRE)–Gennao Bio, a genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced the appointment of Christopher Duke, MBA, M.P.H., as chief executive officer, effective immediately. Mr. Duke succeeds executive chairman and founding chief executive officer, Stephen Squinto, M.D., who will transition to a scientific advisor. “Chris has made significant contributions to … [Read more…]

Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first quarter 2023 financial results after the market close on Wednesday, May 3, 2023. The … [Read more…]

Intera Oncology Showcases Intera 3000 Hepatic Artery Infusion (HAI) Pump at the Annual Cholangiocarcinoma Foundation Conference

Maker of the Only FDA-Approved HAI Therapy Pump Sponsors Event Dedicated to Patients Fighting Bile Duct Cancer BOSTON–(BUSINESS WIRE)–#HAIpump—Intera Oncology® Inc., manufacturer of the only FDA-approved pump for Hepatic Artery Infusion (HAI) therapy for the treatment of intrahepatic cholangiocarcinoma (bile duct cancer confined to the liver) and colorectal cancer liver metastases, will showcase its Intera … [Read more…]

Castle Biosciences to Present at the 22nd Annual Needham Virtual Healthcare Conference

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023, … [Read more…]

Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform

Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif.–(BUSINESS WIRE)–$BRKR #BRKR–Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The … [Read more…]

Melissa Smith Joins ATF Medical’s Adaptive Housing Team

Smith brings over 22 years’ experience and home modification expertise to the role. NEWNAN, Ga.–(BUSINESS WIRE)–#OT–Melissa Smith, OTR/L, CAPS, ECHM, CHAMP recently joined ATF Medical as clinical specialist/adaptive housing. In this role, Smith assesses injured workers and their homes and recommends ways to address barriers to accessibility, mobility and independence. “Melissa has dedicated her OT … [Read more…]

Cutera, Inc. Announces Executive Leadership and Governance Changes

Independent Board Member Sheila A. Hopkins Appointed Interim CEO; Search for Permanent CEO Underway Janet D. Widmann Appointed Independent Chair Executive Chairman Daniel Plants and CEO David Mowry Terminated for Cause Withdraws 2023 Outlook BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced significant changes to … [Read more…]